Welcome to our new careers website! Here you can explore career opportunities, read interview tips & learn about our culture. Questions? Email us at email@example.com.
Your Career Adventure Starts Here
DaVita Clinical Research
DaVita Clinical Research (DCR), a wholly owned subsidiary of DaVita Inc. is a renal research site network with a spectrum of services for clinical drug research and device development. For 30 years we have helped 500+ clients with their development projects. From centralized research services in an integrated, coordinated care delivery model with primary care and multispecialty physicians, we can help plan and execute your next trial.
Who We Are We are group of teammates, headquartered in Minneapolis, spread across all parts of the country. We combine our talents to produce research outcomes within the Village and for sponsors. DCR is proud to have a significant role in the development of every End Stage Renal Disease (ESRD) drug in the last 20 years. We are group of go-getters, while always living out the core value of FUN!
At DCR, our mission is:
Shape the Future of Medicine
Pursuing Life Enhancing Discoveries
Advancing the Practice of Medicine
Expertise in Renal Research Each year, DaVita Inc. treats approximately one-third of the total US end-stage renal disease (ESRD) patient population – about 188,000 patients receiving dialysis — and more than 90,000 patients with chronic kidney disease (CKD).
Our team has a 30-year track record of advancing kidney care and clinical trials, and brings exceptional depth of knowledge and clinical expertise. We employ a resourceful approach to late phase clinical trials in order to help you make confident decisions and meet your late phase study timelines.
Start your Career with DCR
DaVita Clinical Research (DCR), a wholly owned subsidiary of DaVita Inc. — one of the nation’s largest and most innovative healthcare communities. DaVita leverages a shared passion for, and commitment to, clinical excellence and improving patients’ health and quality of life.